Makiz-Pharma enters STADA group and unites businesses with Nizhpharm

September the 3rd, 2007, Moscow. Representatives of three companies announced Makiz-Pharma enters STADA group and unites businesses with Nizhpharm

According to experts’ forecast (DSM Group) the consolidation of Nizhpharm and Makiz-Pharma businesses will bring the unite company to the 2nd place among Russian producers and to the TOP 15 among all market participants with 1.4% market share.

Acquisition of Makiz-Pharma is a continuation of STADA strategy of company’s business development through M&A. Nizhpharm is a bearer of STADA acquisitions policy acting as a initiator of the deal and received all necessary authority from shareholders.

Preparing the official press-conference PR-Premier team delivered consulting support to Nizhpharm, organized the event and delivered media coverage.

Client: Нижфарм